Andy S. Goberdhan, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 701 N Clayton St Ste 500, Wilmington, DE 19805 Phone: 302-421-4860 Fax: 302-421-4159 |
Dr. Yogishchandra A. Patel, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Va Medical Center, Wilmington, DE 19805 Phone: 302-633-5302 Fax: 302-633-5582 |
Dr. Martin F Konwinski, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-633-5302 Fax: 302-633-5582 |
David Spencer Mangum, Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 302-651-4945 |
News Archive
The San Antonio Life Sciences Institute, a joint venture between The University of Texas at San Antonio and The University of Texas Health Science Center at San Antonio, has selected the winners of the Postdoc Initiative Pilot Program.
A new survey has revealed that, although awareness of sepsis is increasing in the US, there are still very few people who are able to recognize the symptoms.
Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has achieved certification to the internationally recognized standard ISO 9001:2015 for its quality management system.
Research is leading to new insights on two major public health challenges: preventing the spread of sexually transmitted infections (STIs) and improving disease control for patients with type 2 diabetes. Expert updates on these critical topics appear in a special symposium section of the January issue of The American Journal of the Medical Sciences (The AJMS), official journal of the Southern Society for Clinical Investigation.
Elbit Imaging Ltd. announces that its associated company (approximately 28% holding on a fully diluted basis), Gamida Cell Ltd. ("Gamida Cell") through the Gamida-Teva Joint Venture (JV), announced today that the Data Monitoring Committee ("DMC") has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx (called ExCell) and has recommended that the JV continue to enroll patients in this study.
› Verified 5 days ago